Clinical Trial Detail

NCT ID NCT04102020
Title A Safety and Efficacy Study of Oral Venetoclax Tablets and Injectable Azacitidine Versus Best Supportive Care as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy to Evaluate Improvement in Relapse-Free Survival (VIALE-M)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AbbVie
Indications

acute myeloid leukemia

Therapies

Azacitidine + Venetoclax

Age Groups: senior adult

No variant requirements are available.